Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial.
第一作者:
Darrell H S,Tan
第一单位:
Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada. darrell.tan@gmail.com.;MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada. darrell.tan@gmail.com.;Department of Medicine, University of Toronto, Toronto, Canada. darrell.tan@gmail.com.;Division of Infectious Diseases, University Health Network, Toronto, Canada. darrell.tan@gmail.com.;Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. darrell.tan@gmail.com.
作者:
医学主题词
抗病毒药(Antiviral Agents);复方合剂(Drug Combinations);住院(Hospitalization);人类(Humans);暴露后预防(Post-Exposure Prophylaxis);随机对照试验(主题)(Randomized Controlled Trials as Topic);利托纳韦(Ritonavir);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.1186/s13063-021-05134-7
PMID
33752741
发布时间
2024-08-08
基金项目
OV4-170652 and VR4-172732/CAPMC/ CIHR/Canada
- 浏览0
Trials
224页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



